Fred S. Apple Fred S. Apple, PhD, Hennepin Healthcare/HCMC, Clinical Laboratories P4, 701 Park Ave, Minneapolis, MN 55415. Email E-mail
Read moreCirculation: Heart Failure, <a href=”https://www.ahajournals.org/toc/circheartfailure/13/7″>Volume 13, Issue 7</a>, July 1, 2020. Source link
Read moreWhat is Known Clinical investigations often rely on self-report as the main method to identify incident events, but it is
Read moreBackground: Among patients with heart failure (HF) with reduced ejection fraction (EF), improvements in left ventricular EF (LVEF) are associated
Read moreDeveloping novel therapies that are safe and effective is challenging, but achieving acceptable certainty of both is imperative. Rigorous evaluation
Read moreCirculation: Heart Failure, <a href=”https://www.ahajournals.org/toc/circheartfailure/13/7″>Volume 13, Issue 7</a>, July 1, 2020. Source link
Read moreWhat is Known Patients with type 2 diabetes mellitus have a higher risk of developing cardiovascular disease and chronic renal
Read moreCirculation: Heart Failure, <a href=”https://www.ahajournals.org/toc/circheartfailure/13/7″>Volume 13, Issue 7</a>, July 1, 2020. Source link
Read moreCirculation: Cardiovascular Quality and Outcomes, <a href=”https://www.ahajournals.org/toc/circoutcomes/13/7″>Volume 13, Issue 7</a>, July 1, 2020. Source link
Read moreCirculation: Heart Failure, <a href=”https://www.ahajournals.org/toc/circheartfailure/13/7″>Volume 13, Issue 7</a>, July 1, 2020. Source link
Read more
